Riskpilot← Back to searchSign inGet full accessAB Servalen
ABActiveOrg 5565283107Östra Strandgatan 10Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19950 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK 3K
+14% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 3K | +14% |
| Total assets | SEK 164K | +2% |
| Equity | SEK 164K | +2% |
| Employees | 0 | — |
Legal name
AB Servalen
Org number
5565283107
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20 december 1995
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet och handel inom ekonomi, jordbruk, skog, industri, medicinsk utrustning, förbrukningsmaterial samt äga fast och lös egendom och därmed förenlig verksamhet.
Address
Östra Strandgatan 10
Email
anders@braherevision.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | −6 | −44 | −13 | −7 | — | — | — | — | — |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — |
| EBIT | −6 | −44 | −13 | −7 | 0 | 0 | 0 | 0 | 0 |
| Net financials | 3 002 | −1 | — | — | — | — | — | 3 | 3 |
| Profit before tax | 2 996 | −45 | −13 | −7 | 0 | 0 | 0 | 3 | 3 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — |
| Net profit | 2 996 | −45 | −13 | −7 | 0 | 0 | 0 | 3 | 3 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10 637 | 193 | 177 | 157 | 157 | 157 | 158 | 160 | 164 |
| Equity | 10 383 | 193 | 164 | 157 | 157 | 157 | 157 | 160 | 164 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 254 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 254 | — | 13 | — | — | — | — | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20162024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20162024
Return on equity
2.1%
This company
18.4%
Market median
-89% vs market
20162024
Net profit margin
342800.0%
This company
8.1%
Market median
+4231999% vs market
20162024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-05-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AB Servalen also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Agneta Ingeborg Helen Barkman | Deputy Board Member | 0 companies |
| Ulf Barkman | Board of Directors | 0 companies |